---
title: blog | Alamar Biosciences
description: Alamar Biosciences |
---

[Skip to content](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/alamar-biosciences#main-content)

[![IPO\_PROPHET\_BLUE logo](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_BLUE%20logo.png?width=2973&height=302&name=IPO_PROPHET_BLUE%20logo.png)](https://www.IPOProphet.com)

- [Login](https://app.ipoprophet.com/login)

Open main navigation

Close main navigation

- [Login](https://app.ipoprophet.com/login)

[Subscribe to our Newsletter](https://share.hsforms.com/1xXldKrGiQBCbNmtOz6j4Jwq3cu4)

[Go Back to Home](http://www.ipoprophet.com/)

[Go Back to Blog](http://www.ipoprophet.com/blog)

[![](https://blog.ipoprophet.com/hubfs/End%20of%20Day%20April%2017th%20Cartoon%20Image-1.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/ipo-class-opens-with-strong-double-digit-premiums-as-follow-through-proves-mixed-led-by-avex-strength)

[2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Aevex](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/aevex), [Kailera Therapeutics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/kailera-therapeutics), [Alamar Biosciences](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/alamar-biosciences)

## [IPO Class Opens With Strong Double-Digit Premiums as Follow-Through Proves Mixed, Led by AVEX Strength](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/ipo-class-opens-with-strong-double-digit-premiums-as-follow-through-proves-mixed-led-by-avex-strength)

![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) 

 Apr 17, 2026, 6:17:03 PM

Friday’s IPO slate — Aevex Corp. (AVEX), Alamar Biosciences (ALMR), and Kailera Therapeutics (KLRA) ...

[![](https://blog.ipoprophet.com/hubfs/Alamar%20Thumbnail%202.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/alamar-biosciences-targets-150m-ipo-as-precision-proteomics-platform-scales-toward-diagnostics)

[2026](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/2026), [Alamar Biosciences](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/alamar-biosciences)

## [Alamar Biosciences Targets ~$150M IPO as Precision Proteomics Platform Scales Toward Diagnostics](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/alamar-biosciences-targets-150m-ipo-as-precision-proteomics-platform-scales-toward-diagnostics)

![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) 

 Apr 14, 2026, 2:29:36 PM

Alamar Biosciences, Inc. (“ALMR”) is seeking to raise approximately $150.0 million in its initial pu...

### Subscribe to our Newsletter

 Email

[linkedin-in icon](https://www.linkedin.com/company/ipo-prophet-software/) [X Twitter icon](https://www.x.com/ipoprophet)

---

[![IPO\_PROPHET\_WHITE-2](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_WHITE-2.png?width=800&height=250&name=IPO_PROPHET_WHITE-2.png "IPO_PROPHET_WHITE-2")](http://www.ipoprophet.com)

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025